Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Improved Characterization of Visual Evoked Potentials in Multiple Sclerosis by Topographic Analysis.
Emerging immunopharmacological targets in multiple sclerosis.
Treatment Satisfaction With Disease Modifying Therapies In Multiple Sclerosis: A Systematic Review of Studies Using The Treatment Satisfaction Questionnaire For Medication (Tsqm).
Lipoic acid reduces inflammation in a mouse focal cortical experimental autoimmune encephalomyelitis model.
Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition.
Increased Affinity of JC Polyomavirus Capsid for LSTc Over Other Sialylated Glycans Is a Major Determinant of Infectivity.
Long-term survival in a patient with progressive multifocal leukoencephalopathy after therapy with rituximab, fludarabine and cyclophosphamide for chronic lymphocytic leukemia.
Microvesicles: What is the Role in Multiple Sclerosis?
SURF1 deficiency causes demyelinating Charcot-Marie-Tooth disease.
More on JC viremia in natalizumab-treated patients with multiple sclerosis.
Postdural Puncture Superior Sagittal Sinus Thrombosis in a Juvenile Case of Clinically Isolated Syndrome.
Psoriasis and comorbidities. Epidemiological studies.
Progressive Multifocal Leukoencephalopathy.
Functional and structural cerebral changes in key brain regions after a facilitation programme for episodic future thought in relapsing-remitting multiple sclerosis patients.
Characterization of the spectrum of Korean inflammatory demyelinating diseases according to the diagnostic criteria and AQP4-Ab status.
HHV-6-positivity in diseases with demyelination.
Serum paraoxonase and arylesterase activity and oxidative status in patients with multiple sclerosis.
[Smoking and multiple sclerosis].
Application of metabolomics in autoimmune diseases: Insight into biomarkers and pathology.
Multiple sclerosis and cerebral endothelial dysfunction: Mechanisms.
Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter.
Bowman-Birk inhibitor concentrate suppresses experimental autoimmune neuritis via shifting macrophages from M1 to M2 subtype.
Gray Matter Volume Reduction Is Associated with Cognitive Impairment in Neuromyelitis Optica.
Perception of muscular effort during dynamic elbow extension in multiple sclerosis.
Frequency, characteristics and consequences of falls in multiple sclerosis: findings from a cohort study.
Pages
« first
‹ previous
…
646
647
648
649
650
651
652
653
654
…
next ›
last »